Company Filing History:
3 out of 122 
1 out of 2 Years Active: 1999-2023
Title: Christoph Kempf: Innovator in Contaminant Removal Methods
Introduction
Christoph Kempf is a notable inventor based in Detligen, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the purification of proteins. With a total of 4 patents to his name, Kempf's work focuses on enhancing the safety and efficacy of pharmaceutical compositions.
Latest Patents
One of Kempf's latest patents is a contaminant removal method for purifying Apo A-I. This innovative method involves providing a solution that includes Apo A-I and guanidine hydrochloride. The solution is then filtered through a specialized filter with a pore size ranging from 15 nm to 35 nm. This process effectively reduces viral contamination of the Apo A-I. The resulting Apo A-I preparation boasts impressive log reduction values, achieving at least a 12 log LRV for parvoviruses, at least 9 log LRV for non-enveloped viruses, and at least 8.5 log LRV for lipid-enveloped viruses. Additionally, the patent includes pharmaceutical compositions and reconstituted high-density lipoprotein formulations that incorporate Apo A-I, along with methods for treating various diseases and disorders.
Career Highlights
Throughout his career, Christoph Kempf has worked with reputable organizations, including CSL Limited and Rotkreuzstiftung Zentrallaboratorium Blutspendedienst SRK. His experience in these companies has allowed him to refine his expertise in biotechnology and patent development.
Collaborations
Kempf has collaborated with several professionals in his field, including Gary Lee Warren and Yvonne Vucica. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Christoph Kempf's innovative work in contaminant removal methods showcases his dedication to improving biotechnological processes. His contributions are vital for the advancement of pharmaceutical safety and efficacy.